MEMO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.130200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.337610E-02
Normal-vs-Stage2
6.090200E-02
Normal-vs-Stage3
4.880000E-02
Normal-vs-Stage4
5.584300E-02
Stage1-vs-Stage2
3.024200E-01
Stage1-vs-Stage3
6.695400E-01
Stage1-vs-Stage4
6.929800E-01
Stage2-vs-Stage3
1.796610E-01
Stage2-vs-Stage4
6.609600E-01
Stage3-vs-Stage4
5.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.881500E-02
Normal-vs-AfricanAmerican
1.524370E-01
Normal-vs-Asian
1.381520E-02
Caucasian-vs-AfricanAmerican
7.128800E-01
Caucasian-vs-Asian
4.266800E-01
AfricanAmerican-vs-Asian
3.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.010400E-02
Normal-vs-Female
5.127700E-02
Male-vs-Female
5.381200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.399500E-02
Normal-vs-Age(41-60Yrs)
6.032000E-02
Normal-vs-Age(61-80Yrs)
3.789600E-02
Normal-vs-Age(81-100Yrs)
4.963900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.815220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.311400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.652650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.620300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.716600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.526800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.936000E-02
Normal-vs-Daily Drinker
9.299700E-02
Normal-vs-Weekly Drinker
3.076100E-02
Normal-vs-Occasional Drinker
1.176470E-02
Normal-vs-Social Drinker
1.955170E-01
Non Drinker-vs-Daily Drinker
8.491000E-01
Non Drinker-vs-Weekly Drinker
9.256600E-01
Non Drinker-vs-Occasional Drinker
6.577800E-01
Non Drinker-vs-Social Drinker
3.730800E-01
Daily Drinker-vs-Weekly Drinker
8.127600E-01
Daily Drinker-vs-Occasional Drinker
8.371200E-01
Daily Drinker-vs-Social Drinker
5.341600E-01
Weekly Drinker-vs-Occasional Drinker
5.997000E-01
Weekly Drinker-vs-Social Drinker
4.043800E-01
Occasional Drinker-vs-Social Drinker
5.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.439200E-01
Normal-vs-Grade 2
9.174400E-01
Normal-vs-Grade 3
8.572400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.408100E-02
Grade 1-vs-Grade 3
7.936600E-03
Grade 1-vs-Grade 4
9.439200E-01
Grade 2-vs-Grade 3
1.949990E-01
Grade 2-vs-Grade 4
9.174400E-01
Grade 3-vs-Grade 4
8.572400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.958300E-02
Normal-vs-NonDiabetic
3.298400E-02
Diabetic-vs-NonDiabetic
6.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.187800E-02
Normal-vs-NoPancreatitis
3.402100E-02
Pancreatitis-vs-NoPancreatitis
9.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.480100E-02
Normal-vs-N1
5.862100E-02
N0-vs-N1
1.671650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.687400E-01
Normal-vs-TP53-NonMutant
4.037700E-02
TP53-Mutant-vs-TP53-NonMutant
4.800300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
